SCHEMBL29978697

SCHEMBL29978697

CC1CCCCN1c1ccccc1NS(=O)(=O)c1ccc(S(=O)(=O)N(C)C)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 2/20 0.52
L3MBTL1 Q9Y468 3/20 0.47
PKM P14618 2/20 0.47
MCOLN3 Q8TDD5 2/20 0.47
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 3/20 0.44
LMNA P02545 3/20 0.44
HPGD P15428 1/20 0.44
CSF1R P07333 1/20 0.44
SCN9A Q15858 1/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 1/20 0.41
MCOLN1 Q9GZU1 1/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
KEAP1 Q14145 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29979662 1.00 MCOLN2 (0.52) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1
SCHEMBL23057141 0.90 GAA (0.45) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1
SCHEMBL29978499 0.86 MCOLN2 (0.44) MCOLN2PKMALDH1A1KDM4ELMNA
SCHEMBL23057173 0.86 MCOLN2 (0.44) MCOLN2PKMALDH1A1KDM4ELMNA
SCHEMBL23057135 0.86 MCOLN2 (0.46) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1
SCHEMBL23057264 0.85 ALDH1A1 (0.49) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1
SCHEMBL29978490 0.85 ALDH1A1 (0.49) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1
SCHEMBL29512769 0.84 ALDH1A1 (0.47) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1
SCHEMBL23057180 0.82 MCOLN3 (0.68) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1
SCHEMBL23043738 0.81 MCOLN3 (0.70) MCOLN2L3MBTL1PKMMCOLN3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 MCOLN2 2/4885L3MBTL1 794/4885PKM 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.